Axel Gaston Glasmacher
Chairman at 4D PHARMA PLC
Axel Gaston Glasmacher active positions
| Companies | Position | Start | End |
|---|---|---|---|
| 4D PHARMA PLC | Independent Dir/Board Member | 2019-01-07 | - |
| Chairman | 2020-04-16 | - | |
| Director/Board Member | 2019-01-07 | 2020-04-16 | |
| RYVU THERAPEUTICS S.A. | Director/Board Member | 2019-09-30 | - |
| ACTIVE BIOTECH AB | Director/Board Member | 2019-12-31 | - |
| Independent Dir/Board Member | 2019-12-31 | - | |
| The Cancer Drug Development Forum | Director/Board Member | - | - |
| Treasurer | - | - | |
| AG Life Science Consulting Gmbh & Co. Kg | Chief Executive Officer | - | - |
| Director/Board Member | 2018-02-28 | - | |
| Glasmacher Verwaltungs GmbH | Chief Executive Officer | - | - |
| Director/Board Member | - | - | |
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Director/Board Member | 2021-06-30 | - |
Career history of Axel Gaston Glasmacher
Former positions of Axel Gaston Glasmacher
| Companies | Position | Start | End |
|---|---|---|---|
| CELGENE | Chief Tech/Sci/R&D Officer | 2006-04-30 | 2018-01-31 |
Training of Axel Gaston Glasmacher
| University of Bonn | Doctorate Degree |
Statistics
International
| Germany | 4 |
| United States | 3 |
| Sweden | 2 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| 4D PHARMA PLC | Health Technology |
| Private companies | 5 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
| The Cancer Drug Development Forum | |
| AG Life Science Consulting Gmbh & Co. Kg | |
| Glasmacher Verwaltungs GmbH | |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Health Technology |